Study of HD Mesh Ablation System for Treatment of Paroxysmal Atrial Fibrillation

Stopped early · Phase 3

Conditions studied: Paroxysmal Atrial Fibrillation

In brief

This is a randomized controlled study of the Bard High Density Mesh Ablation System for treatment of paroxysmal atrial fibrillation. This study will determine if the HD Mesh Ablation System is as safe as and more effective than anti-arrhythmic drugs.

Key facts

Study ID
NCT00741611
Run by
C. R. Bard
People needed
44
Starts
2008-07-01
Expected to finish
2009-11-01
Last updated by the study team
2012-10-26

Who can join

Age: 21 and older, up to 75. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.